These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21107094)

  • 1. Expression of Her-2 in carcinomas of the esophagus.
    Schoppmann SF; Jesch B; Friedrich J; Wrba F; Schultheis A; Pluschnig U; Maresch J; Zacherl J; Hejna M; Birner P
    Am J Surg Pathol; 2010 Dec; 34(12):1868-73. PubMed ID: 21107094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression.
    Birner P; Jesch B; Friedrich J; Riegler M; Zacherl J; Hejna M; Wrba F; Schultheis A; Schoppmann SF
    Ann Surg Oncol; 2011 Nov; 18(12):3330-7. PubMed ID: 21519917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
    König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR
    Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases.
    Schoppmann SF; Jesch B; Zacherl J; Wrba F; Hejna M; Maresch J; Langer FB; Riegler MF; Pluschnig U; Birner P
    Br J Surg; 2011 Oct; 98(10):1408-13. PubMed ID: 21618213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization.
    Rossi E; Villanacci V; Bassotti G; Casa DD; Missale G; Minelli L; Cestari R
    Diagn Mol Pathol; 2006 Sep; 15(3):125-30. PubMed ID: 16932066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
    Thompson SK; Sullivan TR; Davies R; Ruszkiewicz AR
    Ann Surg Oncol; 2011 Jul; 18(7):2010-7. PubMed ID: 21267790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas.
    Fassan M; Ludwig K; Pizzi M; Castoro C; Guzzardo V; Balistreri M; Zaninotto G; Ruol A; Giacomelli L; Ancona E; Rugge M
    Hum Pathol; 2012 Aug; 43(8):1206-12. PubMed ID: 22217477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
    Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
    J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
    D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
    Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
    Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.
    Moskaluk CA; Heitmiller R; Zahurak M; Schwab D; Sidransky D; Hamilton SR
    Hum Pathol; 1996 Nov; 27(11):1211-20. PubMed ID: 8912833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.
    Ooi A; Zen Y; Ninomiya I; Tajiri R; Suzuki S; Kobayashi H; Imoto I; Dobashi Y
    Pathol Int; 2010 Jun; 60(6):466-71. PubMed ID: 20518902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
    Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.
    Naritaka Y; Ogawa K; Shimakawa T; Wagatsuma Y; Isohata N; Asaka S; Miyaki A; Shiozawa S; Katsube T; Yoshimatsu K; Aiba M; Ide H
    Anticancer Res; 2007; 27(1B):505-11. PubMed ID: 17348434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer.
    Siewert JR; Feith M
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S49-53. PubMed ID: 17916519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.